Gabapentin Patent Expiration
Gabapentin was first introduced by Viatris Specialty Llc
Gabapentin Patents
Given below is the list of patents protecting Gabapentin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Gralise | US6340475 | Extending the duration of drug release within the stomach during the fed mode |
Sep 19, 2016
(Expired) | Almatica |
| Gralise | US6488962 | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
Jun 20, 2020
(Expired) | Almatica |
| Gralise | US6635280 | Extending the duration of drug release within the stomach during the fed mode |
Sep 19, 2016
(Expired) | Almatica |
| Gralise | US6723340 | Optimal polymer mixtures for gastric retentive tablets |
Oct 25, 2021
(Expired) | Almatica |
| Gralise | US7438927 | Methods of treatment using a gastric retained gabapentin dosage |
Feb 26, 2024
(Expired) | Almatica |
| Gralise | US7731989 | Gastric retained gabapentin dosage form |
Oct 25, 2022
(Expired) | Almatica |
| Gralise | US8192756 | Gastric retained gabapentin dosage form |
Oct 25, 2022
(Expired) | Almatica |
| Gralise | US8252332 | Gastric retained gabapentin dosage form |
Oct 25, 2022
(Expired) | Almatica |
| Gralise | US8333992 | Gastric retained gabapentin dosage form |
Oct 25, 2022
(Expired) | Almatica |
| Neurontin | US6054482 | Lactam-free amino acids |
Apr 25, 2017
(Expired) | Viatris |
| Neurontin |
US6054482 (Pediatric) | Lactam-free amino acids |
Oct 25, 2017
(Expired) | Viatris |
| Neurontin | US7256216 | Liquid pharmaceutical compositions |
May 28, 2022
(Expired) | Viatris |
| Neurontin |
US7256216 (Pediatric) | Liquid pharmaceutical compositions |
Nov 28, 2022
(Expired) | Viatris |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Gabapentin Generics
Several generic applications have been filed for Gabapentin. The first generic version for Gabapentin was by Actavis Elizabeth Llc and was approved on Sep 12, 2003. And the latest generic version is by Ipca Laboratories Ltd and was approved on May 29, 2024.
Given below is the list of companies who have filed for Gabapentin generic.
1. GRAVITI PHARMS
Graviti Pharmaceuticals Inc has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Graviti Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG | capsule | Prescription | ORAL | AB | Mar 24, 2017 |
| 300MG | capsule | Prescription | ORAL | AB | Mar 24, 2017 |
| 100MG | capsule | Prescription | ORAL | AB | Mar 24, 2017 |
2. TARO
Taro Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/5ML | solution | Prescription | ORAL | AA | Jul 3, 2013 |
| 300MG | capsule | Prescription | ORAL | AB | Aug 2, 2013 |
| 400MG | capsule | Prescription | ORAL | AB | Aug 2, 2013 |
| 100MG | capsule | Prescription | ORAL | AB | Aug 2, 2013 |
3. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule | Prescription | ORAL | AB | Dec 30, 2009 |
| 300MG | capsule | Prescription | ORAL | AB | Dec 30, 2009 |
| 400MG | capsule | Prescription | ORAL | AB | Dec 30, 2009 |
| 800MG | tablet | Discontinued | ORAL | N/A | Oct 16, 2012 |
| 600MG | tablet | Discontinued | ORAL | N/A | Oct 16, 2012 |
4. TEVA
Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Discontinued | ORAL | N/A | Dec 15, 2004 |
| 600MG | tablet | Discontinued | ORAL | N/A | Dec 15, 2004 |
5. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG | capsule | Prescription | ORAL | AB | Oct 16, 2018 |
| 100MG | capsule | Prescription | ORAL | AB | Oct 16, 2018 |
| 300MG | capsule | Prescription | ORAL | AB | Oct 16, 2018 |
| 600MG | tablet | Prescription | ORAL | AB1 | Mar 4, 2024 |
| 800MG | tablet | Prescription | ORAL | AB1 | Mar 4, 2024 |
6. MARKSANS PHARMA
Marksans Pharma Ltd has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Marksans Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG | capsule | Prescription | ORAL | AB | Jul 21, 2011 |
| 300MG | capsule | Prescription | ORAL | AB | Jul 21, 2011 |
| 100MG | capsule | Prescription | ORAL | AB | Jul 21, 2011 |
7. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 1 generic for Gabapentin. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/5ML | solution | Prescription | ORAL | AA | Mar 23, 2012 |
8. IVAX SUB TEVA PHARMS
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG | tablet | Prescription | ORAL | AB1 | Apr 28, 2004 |
| 100MG | tablet | Prescription | ORAL | AB1 | Apr 28, 2004 |
| 300MG | tablet | Prescription | ORAL | AB1 | Apr 28, 2004 |
| 600MG | tablet | Discontinued | ORAL | N/A | Apr 29, 2005 |
| 800MG | tablet | Discontinued | ORAL | N/A | Apr 29, 2005 |
9. INVATECH
Invatech Pharma Solutions Llc has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Invatech.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Discontinued | ORAL | N/A | Jul 6, 2006 |
| 600MG | tablet | Discontinued | ORAL | N/A | Jul 6, 2006 |
10. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule | Prescription | ORAL | AB | Jan 31, 2008 |
| 400MG | capsule | Prescription | ORAL | AB | Jan 31, 2008 |
| 300MG | capsule | Prescription | ORAL | AB | Jan 31, 2008 |
11. APOTEX
Apotex Inc has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Prescription | ORAL | AB1 | Oct 10, 2006 |
| 400MG | tablet | Prescription | ORAL | AB1 | Oct 10, 2006 |
| 300MG | tablet | Prescription | ORAL | AB1 | Oct 10, 2006 |
12. HIKMA PHARMS
Hikma Pharmaceuticals has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Hikma Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG | tablet | Discontinued | ORAL | N/A | Jul 21, 2011 |
| 800MG | tablet | Discontinued | ORAL | N/A | Jul 21, 2011 |
13. PAI HOLDINGS PHARM
Pai Holdings Llc Dba Pharmaceutical Associates Inc has filed for 1 generic for Gabapentin. Given below are the details of the strengths of this generic introduced by Pai Holdings Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/5ML | solution | Discontinued | ORAL | N/A | Dec 3, 2019 |
14. ZYDUS PHARMS USA INC
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB1 | Feb 11, 2011 |
| 600MG | tablet | Prescription | ORAL | AB1 | Feb 11, 2011 |
15. MISSION PHARMACAL
Mission Pharmacal Co has filed for 1 generic for Gabapentin. Given below are the details of the strengths of this generic introduced by Mission Pharmacal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/5ML | solution | Prescription | ORAL | AA | Feb 18, 2011 |
16. IPCA LABS LTD
Ipca Laboratories Ltd has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Ipca Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 300MG | capsule | Prescription | ORAL | AB | Nov 20, 2023 |
| 400MG | capsule | Prescription | ORAL | AB | Nov 20, 2023 |
| 100MG | capsule | Prescription | ORAL | AB | Nov 20, 2023 |
| 800MG | tablet | Prescription | ORAL | AB1 | May 29, 2024 |
| 600MG | tablet | Prescription | ORAL | AB1 | May 29, 2024 |
17. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG | tablet | Discontinued | ORAL | N/A | Mar 10, 2017 |
| 800MG | tablet | Discontinued | ORAL | N/A | Mar 10, 2017 |
18. RANBAXY
Ranbaxy Laboratories Ltd has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Ranbaxy.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG | tablet | Discontinued | ORAL | N/A | Sep 14, 2005 |
| 800MG | tablet | Discontinued | ORAL | N/A | Sep 14, 2005 |
19. WATSON LABS
Watson Laboratories Inc has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule | Discontinued | ORAL | N/A | May 11, 2007 |
| 300MG | capsule | Discontinued | ORAL | N/A | May 11, 2007 |
| 400MG | capsule | Discontinued | ORAL | N/A | May 11, 2007 |
20. HIKMA
Hikma Pharmaceuticals has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule | Discontinued | ORAL | N/A | Sep 25, 2007 |
| 400MG | capsule | Discontinued | ORAL | N/A | Sep 25, 2007 |
| 300MG | capsule | Discontinued | ORAL | N/A | Sep 25, 2007 |
21. LUPIN LTD
Lupin Ltd has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG | tablet | Discontinued | ORAL | N/A | Aug 24, 2018 |
| 800MG | tablet | Discontinued | ORAL | N/A | Aug 24, 2018 |
22. AMNEAL PHARMS NY
Amneal Pharmaceuticals Ny Llc has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Amneal Pharms Ny.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG | capsule | Prescription | ORAL | AB | Jul 25, 2007 |
| 300MG | capsule | Prescription | ORAL | AB | Jul 25, 2007 |
| 100MG | capsule | Prescription | ORAL | AB | Jul 25, 2007 |
23. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule | Discontinued | ORAL | N/A | Aug 24, 2006 |
| 300MG | capsule | Discontinued | ORAL | N/A | Aug 24, 2006 |
| 400MG | capsule | Discontinued | ORAL | N/A | Aug 24, 2006 |
| 800MG | tablet | Prescription | ORAL | AB1 | Aug 24, 2006 |
| 600MG | tablet | Prescription | ORAL | AB1 | Aug 24, 2006 |
24. ACELLA PHARMS LLC
Acella Pharmaceuticals Llc has filed for 1 generic for Gabapentin. Given below are the details of the strengths of this generic introduced by Acella Pharms Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/5ML | solution | Prescription | ORAL | AA | May 1, 2012 |
25. ZHEJIANG YONGTAI
Zhejiang Yongtai Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Zhejiang Yongtai.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG | capsule | Prescription | ORAL | AB | Aug 17, 2020 |
| 300MG | capsule | Prescription | ORAL | AB | Aug 17, 2020 |
| 100MG | capsule | Prescription | ORAL | AB | Aug 17, 2020 |
26. LAURUS
Laurus Labs Ltd has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Laurus.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule | Prescription | ORAL | AB | May 12, 2023 |
| 400MG | capsule | Prescription | ORAL | AB | May 12, 2023 |
| 300MG | capsule | Prescription | ORAL | AB | May 12, 2023 |
| 600MG | tablet | Prescription | ORAL | AB1 | Apr 8, 2024 |
| 800MG | tablet | Prescription | ORAL | AB1 | Apr 8, 2024 |
27. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG | tablet | Prescription | ORAL | AB2 | Jan 24, 2024 |
| 300MG | tablet | Prescription | ORAL | AB2 | Jan 24, 2024 |
28. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule | Prescription | ORAL | AB | Sep 12, 2003 |
| 400MG | capsule | Prescription | ORAL | AB | Sep 12, 2003 |
| 300MG | capsule | Prescription | ORAL | AB | Sep 12, 2003 |
| 800MG | tablet | Prescription | ORAL | AB1 | Oct 21, 2004 |
| 600MG | tablet | Prescription | ORAL | AB1 | Oct 21, 2004 |
29. BELCHER
Belcher Pharmaceuticals Llc has filed for 1 generic for Gabapentin. Given below are the details of the strengths of this generic introduced by Belcher.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/5ML | solution | Prescription | ORAL | AA | Mar 14, 2016 |
30. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2006 |
| 800MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2006 |
| 400MG | capsule | Discontinued | ORAL | N/A | Oct 26, 2017 |
| 100MG | capsule | Discontinued | ORAL | N/A | Oct 26, 2017 |
| 300MG | capsule | Discontinued | ORAL | N/A | Oct 26, 2017 |
31. SANDOZ
Sandoz Inc has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule | Discontinued | ORAL | N/A | Jan 24, 2006 |
| 400MG | capsule | Discontinued | ORAL | N/A | Jan 24, 2006 |
| 300MG | capsule | Discontinued | ORAL | N/A | Jan 24, 2006 |
32. ALKEM
Alkem Laboratories Ltd has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Alkem.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG | capsule | Prescription | ORAL | AB | Dec 17, 2010 |
| 100MG | capsule | Prescription | ORAL | AB | Dec 17, 2010 |
| 300MG | capsule | Prescription | ORAL | AB | Dec 17, 2010 |
33. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB1 | Feb 4, 2016 |
| 600MG | tablet | Prescription | ORAL | AB1 | Feb 4, 2016 |
| 100MG | capsule | Prescription | ORAL | AB | Feb 18, 2016 |
| 400MG | capsule | Prescription | ORAL | AB | Feb 18, 2016 |
| 300MG | capsule | Prescription | ORAL | AB | Feb 18, 2016 |
34. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 300MG | capsule | Discontinued | ORAL | N/A | Jun 30, 2005 |
| 400MG | capsule | Discontinued | ORAL | N/A | Jun 30, 2005 |
| 100MG | capsule | Discontinued | ORAL | N/A | Jun 30, 2005 |
35. ASCENT PHARMS INC
Ascent Pharmaceuticals Inc has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG | capsule | Prescription | ORAL | AB | May 10, 2021 |
| 300MG | capsule | Prescription | ORAL | AB | May 10, 2021 |
| 100MG | capsule | Prescription | ORAL | AB | May 10, 2021 |
| 800MG | tablet | Prescription | ORAL | AB1 | Oct 1, 2021 |
| 600MG | tablet | Prescription | ORAL | AB1 | Oct 1, 2021 |
36. HUMANWELL
Humanwell Pharmaceutical Us Inc has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Humanwell.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 300MG | tablet | Prescription | ORAL | AB2 | Feb 26, 2024 |
| 600MG | tablet | Prescription | ORAL | AB2 | Feb 26, 2024 |
37. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG | tablet | Prescription | ORAL | AB1 | Aug 18, 2006 |
| 800MG | tablet | Prescription | ORAL | AB1 | Aug 18, 2006 |
38. RUBICON
Rubicon Research Private Ltd has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Rubicon.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB1 | Sep 13, 2006 |
| 600MG | tablet | Prescription | ORAL | AB1 | Sep 13, 2006 |
| 250MG/5ML | solution | Prescription | ORAL | AA | Jan 18, 2023 |
39. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Discontinued | ORAL | N/A | Jun 1, 2010 |
| 600MG | tablet | Discontinued | ORAL | N/A | Jun 1, 2010 |
40. MYLAN
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule | Discontinued | ORAL | N/A | Feb 14, 2011 |
| 300MG | capsule | Discontinued | ORAL | N/A | Feb 14, 2011 |
| 400MG | capsule | Discontinued | ORAL | N/A | Feb 14, 2011 |
41. CSPC OUYI
Cspc Ouyi Pharmaceutical Co Ltd has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Cspc Ouyi.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 300MG | capsule | Prescription | ORAL | AB | Mar 23, 2005 |
| 100MG | capsule | Prescription | ORAL | AB | Mar 23, 2005 |
| 400MG | capsule | Prescription | ORAL | AB | Mar 23, 2005 |
| 600MG | tablet | Prescription | ORAL | AB1 | Oct 26, 2017 |
| 800MG | tablet | Prescription | ORAL | AB1 | Oct 26, 2017 |
42. RISING
Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB1 | Jul 19, 2023 |
| 600MG | tablet | Prescription | ORAL | AB1 | Jul 19, 2023 |
43. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 300MG | capsule | Discontinued | ORAL | N/A | Oct 8, 2004 |
| 100MG | capsule | Discontinued | ORAL | N/A | Oct 8, 2004 |
| 400MG | capsule | Discontinued | ORAL | N/A | Oct 8, 2004 |
44. ACI
Aci Healthcare Ltd has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Aci.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB1 | Jul 12, 2013 |
| 600MG | tablet | Prescription | ORAL | AB1 | Jul 12, 2013 |
| 400MG | capsule | Prescription | ORAL | AB | May 14, 2018 |
| 100MG | capsule | Prescription | ORAL | AB | May 14, 2018 |
| 300MG | capsule | Prescription | ORAL | AB | May 14, 2018 |
45. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG | tablet | Prescription | ORAL | AB1 | Oct 6, 2011 |
| 800MG | tablet | Prescription | ORAL | AB1 | Oct 6, 2011 |
46. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB1 | Dec 23, 2015 |
| 600MG | tablet | Prescription | ORAL | AB1 | Dec 23, 2015 |
47. ANNORA PHARMA
Annora Pharma Private Ltd has filed for 3 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Annora Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/5ML | solution | Prescription | ORAL | AA | Jan 17, 2024 |
| 600MG | tablet | Prescription | ORAL | AB2 | Feb 26, 2024 |
| 300MG | tablet | Prescription | ORAL | AB2 | Feb 26, 2024 |
48. GRANULES
Granules India Ltd has filed for 5 different strengths of generic version for Gabapentin. Given below are the details of the strengths of this generic introduced by Granules.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule | Prescription | ORAL | AB | Apr 6, 2005 |
| 300MG | capsule | Prescription | ORAL | AB | Apr 6, 2005 |
| 400MG | capsule | Prescription | ORAL | AB | Apr 6, 2005 |
| 800MG | tablet | Prescription | ORAL | AB1 | Mar 28, 2023 |
| 600MG | tablet | Prescription | ORAL | AB1 | Mar 28, 2023 |